The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Enteropathic Arthritis

Spondyloarthritis associated with inflammatory bowel disease

Written by: Saygı Hospital Health Guide Editorial Board
Published:

This content is for general information; please consult your physician for diagnosis and treatment.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dahiliye (İç Hastalıkları) department. Book Appointment →

What is Enteropathic Arthritis?

Enteropathic arthritis is a rheumatologic manifestation of inflammatory bowel disease (IBD) sharing pathogenic features with spondyloarthritis — HLA-B27 association (axial form), IL-23/IL-17 axis activation, gut–joint immune crosstalk, and enthesitis-driven inflammation.

Two main peripheral subtypes — type 1: acute, asymmetric, oligoarticular (≤5 joints, lower extremity), self-limiting, parallels IBD flare; type 2: chronic, symmetric, polyarticular (≥5 joints, upper extremity), independent of bowel activity.

Axial enteropathic arthritis resembles ankylosing spondylitis with inflammatory back pain, sacroiliitis, and progressive spinal involvement, often independent of bowel disease activity and may precede IBD diagnosis.

Coexistence of extraintestinal manifestations — uveitis, pyoderma gangrenosum, erythema nodosum, primary sclerosing cholangitis; treatment choices must avoid worsening of either bowel or joint disease (NSAID GI toxicity, etanercept ineffective for IBD).

Symptoms

Peripheral arthritis — type 1: oligoarticular, asymmetric, lower limb, parallels IBD activity; type 2: polyarticular, symmetric, upper limb, chronic, IBD-independent
Axial disease — inflammatory back pain, morning stiffness, reduced spinal mobility, sacroiliitis on imaging
Enthesitis — Achilles tendon, plantar fascia; dactylitis — sausage digit
Extra-articular — erythema nodosum, pyoderma gangrenosum, oral aphthae, uveitis, episcleritis
Primary sclerosing cholangitis in ulcerative colitis; osteoporosis and vertebral fractures from chronic inflammation and steroid use
Gastrointestinal — abdominal pain, diarrhea (bloody in UC), weight loss, anemia, fistulas/strictures in Crohn

Risk Factors

Underlying inflammatory bowel disease (Crohn disease or ulcerative colitis)
HLA-B27 positivity (axial involvement)
Active bowel disease and disease duration
Extraintestinal manifestations of IBD (uveitis, erythema nodosum)
Family history of IBD or spondyloarthritis
Smoking (worse Crohn outcomes), certain dietary and environmental factors

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Patients with known IBD developing arthritis, inflammatory back pain, enthesitis, or uveitis should undergo rheumatology referral with coordinated gastroenterology management.
  • Patients with axial spondyloarthritis or peripheral arthritis presenting with chronic diarrhea, bloody stools, or weight loss should have gastroenterology evaluation for undiagnosed IBD including colonoscopy and biopsies.
  • Severe pain crisis, acute abdomen, high-volume GI bleeding, new fistula, or suspected toxic megacolon requires urgent hospital evaluation and multidisciplinary management.

Treatment Methods

01
Non-pharmacologic — physical therapy, exercise, smoking cessation, nutritional support, and stress management; avoid NSAIDs in active IBD as they may precipitate flares.
02
Mild peripheral arthritis — short-course low-dose NSAIDs with careful GI monitoring, intra-articular steroids, local glucocorticoids; sulfasalazine effective for both peripheral arthritis and colitis.
03
Conventional DMARDs — methotrexate for peripheral arthritis; azathioprine benefits both IBD and arthritis; consider response by domain and IBD activity.
04
Biologic therapy — TNF-α inhibitors (infliximab, adalimumab, golimumab, certolizumab) effective for both IBD and spondyloarthritis; avoid etanercept (not effective for IBD) and IL-17 inhibitors (may worsen IBD).
05
IL-12/23 inhibitor (ustekinumab), IL-23 inhibitors (risankizumab, guselkumab), and JAK inhibitors (upadacitinib, tofacitinib) are alternative options effective across both domains; vedolizumab for IBD primarily, may not treat axial disease.
06
Extraintestinal complications — ophthalmology for uveitis, dermatology for skin lesions, hepatology for primary sclerosing cholangitis; bone health with calcium, vitamin D, and DXA; vaccinations per EULAR and ECCO guidelines.

Which Department to Visit?

You can visit our Dahiliye (İç Hastalıkları) department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dahiliye (İç Hastalıkları) Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.